GlassScriptPhysician profile
Gregory J Grabowski
NPI 1649335019
$34,250.19
in general payments reported to CMS, 2019-2025
10 companies · $3,702 in 2025
The $3,702 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,982 · 2020: $31.12 · 2021: $10K · 2022: $5,846 · 2023: $6,337 · 2024: $3,147 · 2025: $3,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $13K · Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $12,768.47 |
| Food and Beverage | $418.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $33,773.94 | 2019-2025 | Minirail System, Physio-Stim, Calcaneal Minifixator |
| Stryker Corporation | $162.97 | 2023 | Augment Injectable, Citrefix, Easyfuse |
| Nevro Corp. | $95.87 | 2023 | Senza |
| Organogenesis INC. | $71.23 | 2024-2025 | Puraply Wound Matrix |
| Horizon Therapeutics Plc | $43.99 | 2019-2020 | |
| Access Pro Medical, LLC | $43.46 | 2025 | Matriderm |
| Fusion Orthopedics USA, LLC | $15.63 | 2025 | |
| Invictus Surgical Incorporated | $14.69 | 2025 | |
| Reprise Biomedical, INC. | $14.43 | 2024 | Miro3d |
| Abbott Laboratories | $13.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Grabowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.